These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8259152)

  • 21. [Risk factors for dying among ibopamine users].
    Vandenbroucke JP
    Ned Tijdschr Geneeskd; 1999 Jul; 143(31):1631-2. PubMed ID: 10488378
    [No Abstract]   [Full Text] [Related]  

  • 22. Vesnarinone-induced granulocytopenia: incidence in Japan and recommendations for safety.
    Furusawa S; Ohashi Y; Asanoi H
    J Clin Pharmacol; 1996 May; 36(5):477-81. PubMed ID: 8739027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral heart failure medications: an update for home health clinicians.
    Cheek DJ; Sherrod MM; Graulty R; Hawkins J
    Home Healthc Nurse; 2008; 26(10):600-11; quiz 612-3. PubMed ID: 19001915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypertension and heart failure. Are there approaches for differential therapy?].
    Böhm M
    MMW Fortschr Med; 2000 Feb; 142(7):31-3. PubMed ID: 10832331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Essential basics in therapy of heart failure. Without diuretics the prognosis is poor].
    Bischoff A
    MMW Fortschr Med; 2002 Jul; 144(29-30):6-8. PubMed ID: 12219622
    [No Abstract]   [Full Text] [Related]  

  • 26. [A new drug against heart failure was retracted after an alarm about increased mortality].
    Lennholm B
    Lakartidningen; 1993 Aug; 90(32-33):2682-3. PubMed ID: 8361279
    [No Abstract]   [Full Text] [Related]  

  • 27. [Risk factors for dying among ibopamine users].
    de Graeff PA; Elferink AJ; Lekkerkerker JF
    Ned Tijdschr Geneeskd; 1999 May; 143(21):1114-5. PubMed ID: 10368748
    [No Abstract]   [Full Text] [Related]  

  • 28. Digoxin.
    Hampton JR
    Br J Hosp Med; 1997 Oct 1-14; 58(7):321-3. PubMed ID: 9509052
    [No Abstract]   [Full Text] [Related]  

  • 29. The flosequinan experience and its implications.
    Fath-Ordoubadi F
    Br J Hosp Med; 1993 Dec 15-1994 Jan 18; 50(11):683; author reply 683-4. PubMed ID: 8124555
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy.
    Stevenson LW
    Circulation; 2003 Jul; 108(4):492-7. PubMed ID: 12885733
    [No Abstract]   [Full Text] [Related]  

  • 31. [Positive ionotropic substances (digitoxin and digoxin). Principles and rules of use].
    Gelu M; Caron J; Libersa C
    Rev Prat; 1999 May; 49(9):1017-23. PubMed ID: 11865453
    [No Abstract]   [Full Text] [Related]  

  • 32. [Is heart rate reduction beneficial to patients with heart insufficiency? Focus on beta-blockade].
    Henriksen OM; Gadsbøll N
    Ugeskr Laeger; 2002 Jan; 164(5):615-9. PubMed ID: 11871210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study of heart failure. Is phytotherapy effective?].
    MMW Fortschr Med; 2001 Jun; 143(25):59. PubMed ID: 11469004
    [No Abstract]   [Full Text] [Related]  

  • 34. Through the looking glass: a positive inotropic drug and ischemic preconditioning.
    Vander Heide RS; Marsh JD
    Circulation; 1997 Apr; 95(8):1989-91. PubMed ID: 9133503
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of ischemic and nonischemic heart failure. Current status and prospects].
    Weil J; Riegger G
    Internist (Berl); 2002 Apr; 43 Suppl 1():S8, S11-8. PubMed ID: 11993003
    [No Abstract]   [Full Text] [Related]  

  • 36. Whither Withering's Legacy? Digoxin's role in our contemporary pharmacopeia for heart failure.
    Young JB
    J Am Coll Cardiol; 2005 Aug; 46(3):505-7. PubMed ID: 16053965
    [No Abstract]   [Full Text] [Related]  

  • 37. Present status of various inotropic agents in heart failure.
    Mittal SR; Maheshwari N
    J Assoc Physicians India; 2001 Nov; 49():1095-9. PubMed ID: 11868865
    [No Abstract]   [Full Text] [Related]  

  • 38. Transient dobutamine-mediated pulsus alternans.
    Kahn JH; Starling MR; Supiano MA
    Can J Cardiol; 2001 Feb; 17(2):203-5. PubMed ID: 11223491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inotropic agents in advanced and refractory heart failure].
    Mangiavacchi M; Gronda E
    Ital Heart J Suppl; 2003 Jan; 4(1):3-7. PubMed ID: 12690928
    [No Abstract]   [Full Text] [Related]  

  • 40. Neutropenia occurring during treatment with vesnarinone (OPC-8212).
    Bertolet BD; White BG; Pepine CJ
    Am J Cardiol; 1994 Nov; 74(9):968-70. PubMed ID: 7526678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.